Latest Articles
‘No surgery, no chemo’: new cancer trial shows 100% remission with immunotherapy - Mathrubhumi English
‘No surgery, no chemo’: new cancer trial shows 100% remission with immunotherapy Mathrubhumi English
Published: May 6, 2025, 10:03 a.m.
Molecular profiling reduces need for radiotherapy in endometrial cancer - indica News
Molecular profiling reduces need for radiotherapy in endometrial cancer indica News
Published: May 5, 2025, 1:49 p.m.
Unmet Needs and Gaps in Treatment Options for Advanced EC Post-IO Therapy - OncLive
Unmet Needs and Gaps in Treatment Options for Advanced EC Post-IO Therapy OncLive
Published: May 5, 2025, 12:35 p.m.
Watch 9News Latest Stories - Season 2025 - New therapy combating high cholesterol - 9Now
Watch 9News Latest Stories - Season 2025 - New therapy combating high cholesterol 9Now
Published: May 2, 2025, 9:37 a.m.
Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort - BioSpace
Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort BioSpace
Published: April 30, 2025, 5:52 a.m.
Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma - OncLive
Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma OncLive
Published: April 28, 2025, 1:18 p.m.
Comprehensive single-cell transcriptome analysis of autologous platelet-rich plasma therapy on human thin endometrium - Nature
Comprehensive single-cell transcriptome analysis of autologous platelet-rich plasma therapy on human thin endometrium Nature
Published: April 26, 2025, 9:58 a.m.
A Dual-Interaction Supramolecular Hydrogel System for siRNA Delivery to Enhance Endometrial Receptivity in Stem Cell Therapy - ACS Publications
A Dual-Interaction Supramolecular Hydrogel System for siRNA Delivery to Enhance Endometrial Receptivity in Stem Cell Therapy ACS Publications
Published: April 25, 2025, 11:16 p.m.
Dr Agustí Garcia on Patient Eligibility for Evaluating Chemoradiotherapy vs Radiotherapy Alone in Intermediate-Risk Cervical Cancer - OncLive
Dr Agustí Garcia on Patient Eligibility for Evaluating Chemoradiotherapy vs Radiotherapy Alone in Intermediate-Risk Cervical Cancer OncLive
Published: April 21, 2025, 7:21 p.m.
Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer - OncLive
Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer OncLive
Published: April 21, 2025, 1:17 p.m.
Link copied to clipboard!